Literature DB >> 6590934

Use of logistic regression analysis to improve prediction of prognosis in acute myeloid leukaemia.

R Bailey-Wood, C M Dallimore, S A Smith, J A Whittaker.   

Abstract

The prognostic usefulness of a range of factors has been examined for patients with acute myeloid leukaemia. Although there was a statistical association between some of these factors and remission rate, the association was only partial. To improve the usefulness of the data, multiple logistic regressional analysis was used. The features selected for use in the analysis were age, blood blast count, FAB classification and colony growth pattern. The last three features could be used as categorical variables, since blood blast counts of greater than 100 X 10(9)/1, FAB group 1 and a prolific pattern of colony growth were associated with a low remission rate. Age was used as a continuous variable. Using these features, eight regression groups were defined. Thus when this data for an individual patient is analysed, it is possible to obtain a value for the probability of that patient achieving remission.

Entities:  

Mesh:

Year:  1984        PMID: 6590934     DOI: 10.1016/0145-2126(84)90015-8

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Simple method for granulocyte-macrophage cell culture and staining in soft agar: comparison with a standard research technique.

Authors:  K Hyde; A J Steed; H Lenehan; M J Saunders; J T Richards; J A Lin Yin; C G Geary
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

2.  Myeloid surface antigen abnormalities in myelodysplasia: relation to prognosis and modification by 13-cis retinoic acid.

Authors:  R E Clark; S A Smith; A Jacobs
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

3.  Reduced in vitro erythroid progenitor cell growth in bronchial cancer.

Authors:  G S Masters; P Baines; R Bailey-Wood; T Gorvett; T Littlewood; P Bentley; H Parry-Jones; A Jacobs
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.